Apocrine carcinomas carry a distinct immunohistochemical profile represented by the negative expression of estrogen receptor (ER) and progesterone receptor (PR), with positive expression of androgen receptor (AR) and gross cystic disease fluid protein-15 (GCDFP-15). The gene discussed is PGR; the disease is apocrine adenocarcinoma.